When does gout need treatment? A new set of staging criteria hopes to clarify the answer, and a separate report warns of the risks of unjustified treatment.
Medication adherence among gout patients is poorer than for many other chronic conditions. Authors of a systematic review point to some probable explanations.
Data from two large prospective studies confirm earlier suggestions that gout risk is increased among patients with psoriasis and psoriatic arthritis, independent of possible contributing factors such as metabolic syndrome.
Updating the evidence on gout treatment, a systematic review assesses how to offer the best for gout patients while keeping their comorbidities in mind.
A new study resolves weaknesses in earlier research to provide clearer guidance about alcohol and gout. Any type of alcohol, including wine, can trigger gout attacks.
Could gout go the way of smallpox? It might, if only everyone would follow the guidelines available for management, says an editorial.
Why are gout patients seeking treatment from their healthcare providers at three times the rate they were in the later 20th century? Researchers suggest that better disease awareness and an aging population may hold the answers.
ACR2013: Dual-energy computed tomography (DECT) proves a much clearer picture in complicated cases where gout may be challenging to diagnose.
ACR2013: Urate crystals turned up in dual-energy CT and pathology studies of OA patients never diagnosed with gout who came to the Mayo Clinic for knee replacement, raising intriguing questions.
Pegloticase may reduce or eradicate the urate crystal mass in painful gout tophi, according to phase 3 trial results.